ACTRN12605000687695已完成1 期
A proof of concept, single centre, monotherapy, dose-ranging trial to evaluate the efficacy and tolerability of CB0011 at 0,7.5, 15, 30 and 45mg in Obstructive Sleep Apnea.
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 42
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 21 Years 至 ot stated（—）
- 性别
- All
入选标准
- •Subjects must have a current diagnosis of Obstructive Sleep Apnea, have an apnea-hypopnea index (AHI) of between 10-40 (using a strict definition of hypopnea), with a calculated BMI equal or less than 40 at the time of study entry.
排除标准
- •No exclusion criteria
研究者
相似试验
尚未招募
4 期
se Of Beejpushti Rasa in treatment of low sperm count.CTRI/2022/03/041380MS Shree Dhootapapeshwar Limited
招募中
4 期
Exploring the Efficacy of P Grace: A Promising Intervention for Managing Benign Prostatic Hyperplasia (BPH) - An Open-Label, Single-Centric Clinical StudyCTRI/2023/11/060343utra Grace
已完成
不适用
A clinical study to compare the efficay and safety of Instavit oral spray for the Occassional SleeplessnessCTRI/2017/09/009834Instavit Ltd50
进行中（未招募）
不适用
Single center, therapeutic exploratory clinical trial to evaluate the safety of sodium oxybate (Xyrem) 500 mg/mL oral solution on potential endocrine changes at currently labeled therapeutic dose regimens (4.5 g/day divided into two equal doses)during twelve weeks of treatment of cataplexy in adult patients with narcolepsy. - C00301EUCTR2005-004417-15-BECB Pharma Ltd25
进行中（未招募）
1 期
A single centre, randomised, single (patient) blind, single dose, parallel group exploratory study to compare the efficacy of an 8.75mg flurbiprofen lozenge (Strefen) with a 3mg benzydamine lozenge (Difflam) following oral administration in 200 subjects with sore throat. - Comparator study of Strefen and DifflamSore throat suitable for treatment in an OTC setting.EUCTR2005-003588-22-GBBoots Healthcare International Limited200